| ELOCTA 2000 IU powder and solvent for solution for injection EU/1/15/1046/006 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB |
— |
| ELOCTA 250 IU powder and solvent for solution for injection EU/1/15/1046/001 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB |
— |
| ELOCTA 3000 IU powder and solvent for solution for injection EU/1/15/1046/007 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB |
— |
| ELOCTA 4000 IU powder and solvent for solution for injection EU/1/15/1046/008 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ELOCTA 500 IU powder and solvent for solution for injection EU/1/15/1046/002 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB |
— |
| ELOCTA 750 IU powder and solvent for solution for injection EU/1/15/1046/003 |
Efmoroctocog alfa |
Swedish Orphan Biovitrum AB |
— |
| Elonva 100 micrograms solution for injection EU/1/09/609/001 |
Corifollitropin alfa |
N.V. Organon |
— |
| Elonva 150 micrograms solution for injection EU/1/09/609/002 |
Corifollitropin alfa |
N.V. Organon |
— |
| ELREXFIO 40 mg/mL solution for injection EU/1/23/1770/001-002 |
Elranatamab |
Pfizer Europe MA EEIG |
— |
| Eltrombopag Accord 12.5 mg film-coated tablets EU/1/24/1903/001-004 |
Eltrombopag olamine |
Accord Healthcare S.L.U. |
— |
| Eltrombopag Accord 25 mg film-coated tablets EU/1/24/1903/005-010 |
Eltrombopag olamine |
Accord Healthcare S.L.U. |
— |
| Eltrombopag Accord 50 mg film-coated tablets EU/1/24/1903/011-016 |
Eltrombopag olamine |
Accord Healthcare S.L.U. |
— |
| Eltrombopag Accord 75 mg film-coated tablets EU/1/24/1903/017-022 |
Eltrombopag olamine |
Accord Healthcare S.L.U. |
— |
| Eltrombopag MSN 25 mg film-coated tablets PA23250/011/001 |
Eltrombopag olamine |
MSN Labs Europe Limited |
Not marketed |
| Eltrombopag MSN 50 mg film-coated tablets PA23250/011/002 |
Eltrombopag olamine |
MSN Labs Europe Limited |
Not marketed |
| Eltrombopag Viatris 12.5 mg film-coated tablets EU/1/24/1869/001-004 |
Eltrombopag olamine |
Viatris Limited |
— |
| Eltrombopag Viatris 25 mg film-coated tablets EU/1/24/1869/005-008 |
Eltrombopag olamine |
Viatris Limited |
— |
| Eltrombopag Viatris 50 mg film-coated tablets EU/1/24/1869/009-012 |
Eltrombopag olamine |
Viatris Limited |
— |
| Eltrombopag Viatris 75 mg film-coated tablets EU/1/24/1869/013-016 |
Eltrombopag olamine |
Viatris Limited |
— |
| Elucirem 0.5mmol/mL solution for injection EU/1/23/1772/001-010 |
Gadopiclenol |
Guerbet |
— |
| ELZONRIS 1 mg/mL concentrate for solution for infusion EU/1/20/1504/001 |
Tagraxofusp |
TMC Pharma (EU) Limited |
— |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/001 |
Emedastine difumarate |
Immedica Pharma AB |
— |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/003 |
Emedastine difumarate |
Immedica Pharma AB |
— |
| EMADINE 0.5 mg/ml, eye drops, solution EU/1/98/095/004 |
Emedastine difumarate |
Immedica Pharma AB |
— |
| Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusion EU/1/24/1808/001 |
Avibactam sodium, Aztreonam beta form |
Pfizer Europe MA EEIG |
— |
| Emcitate 350 microgram dispersible tablets EU/1/24/1897/001 |
Tiratricol |
Rare Thyroid Therapeutics International AB |
— |
| EMEND 125 mg hard capsules EU/1/03/262/004-005 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| EMEND 125 mg hard capsules EMEND 80 mg hard capsules EU/1/03/262/006 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| Emend 125 mg powder for oral suspension EU/1/03/262/011 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| EMEND 80 mg hard capsules EU/1/03/262/001-003 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| Emgality EU/1/18/1330/001-004 |
GALCANEZUMAB |
Eli Lilly Nederland B.V. |
— |
| Empliciti 300 mg powder for concentrate for solution for infusion. EU/1/16/1088/001 |
Elotuzumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Empliciti 400 mg powder for concentrate for solution for infusion. EU/1/16/1088/002 |
Elotuzumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| EMSELEX EU/1/04/294/1-12 |
Darifenacin hydrobromide |
pharmaand GmbH |
— |
| Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris 200 mg/25 mg/25 mg film-coated tablets EU/1/25/1966/001-006 |
Emtricitabine, Rilpivirine, Tenofovir alafenamide |
Viatris Limited |
— |
| Emtricitabine/Tenofovir alafenamide Viatris 200 mg/10 mg film-coated tablets EU/1/25/1952/001-002 |
Emtricitabine |
Viatris Limited |
— |
| Emtricitabine/Tenofovir alafenamide Viatris 200 mg/25 mg film-coated tablets EU/1/25/1952/003-008 |
Emtricitabine |
Viatris Limited |
— |
| Emtricitabine/Tenofovir disoproxil Krka 200 mg/245 mg film-coated tablets EU/1/16/1151/001-004 |
Emtricitabine, Tenofovir disoproxil |
KRKA, d.d., Novo mesto |
— |
| Emtricitabine/Tenofovir disoproxil Krka d.d 200 mg/245 mg film-coated tablets EU/1/17/1182/001-004 |
Tenofovir disoproxil, Emtricitabine |
KRKA, d.d., Novo mesto |
— |
| Emtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg film-coated tablets EU/1/16/1133/001-006 |
Emtricitabine, Tenofovir disoproxil |
Mylan Pharmaceuticals Limited |
— |
| Emtricitabine/Tenofovir disoproxil Zentiva 200 mg/245 mg film-coated tablets EU/1/16/1148/001-002 |
Tenofovir disoproxil, Emtricitabine |
Zentiva k.s. |
— |
| Emtriva 200 mg hard capsules EU/1/03/261/1-3 |
Emtricitabine |
Gilead Sciences Ireland UC |
— |
| Enbrel 10 mg Powder and solvent for solution for injection EU/1/99/126/022 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Powder for solution for injection EU/1/99/126/001-003 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Powder for solution for injection EU/1/99/126/002 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Solution for injection EU/1/99/126/013-015 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Solution for injection EU/1/99/126/023-025 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 50 mg Solution for injection EU/1/99/126/016-021 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| EndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solution EU/1/16/1105/001-002 |
Lutetium (177lu) chloride |
ITM Medical Isotopes GmbH |
— |
| Enerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules EU/1/20/1438/001-005 |
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate |
Novartis Europharm Limited |
— |